I help medical technology and life sciences companies build world-class operations, launch products successfully, and scale with confidence. With 20+ years of executive leadership at Medtronic, Smith+Nephew, and in the startup world, I bring the expertise of a Fortune 500 operations executive with the agility and focus of a dedicated advisor.
Jen Walsh is a senior MedTech consulting advisor specializing in biologics operations, regenerative medicine commercialization, and manufacturing strategy for medical device and life sciences companies navigating growth, transformation, or product launch.
Over two decades at Medtronic — including leadership of a $175M biologics operation spanning tissue-based biologics, bone grafting, and stem cell manufacturing — she personally commercialized nine named products across FDA 510(k) and PMA pathways. As a Lean Sigma Master Black Belt, she delivered $100M in cumulative savings across 13 global manufacturing sites, and created a revenue-based Business Continuity Management model that was adopted enterprise-wide at Medtronic.
Her experience spans the full arc of the industry: Fortune 500 executive leadership at Medtronic and Smith+Nephew, and founder-level startup experience as CTO of M2 Medical Innovations — fundraising, IP strategy, and regulatory pathway included. Clients get an advisor who has actually run the operations they are trying to build.
Global manufacturing strategy for tissue-based biologics and regenerative medicine — built on two decades leading Medtronic's $175M biologics operation.
Nine named products personally commercialized across 510(k) and PMA pathways — from design controls through launch readiness.
$100M in cumulative savings delivered as a Lean Sigma Master Black Belt across 13 global sites — including proprietary, award-winning CI programs.
Creator of a revenue-based BCM model piloted in Medtronic's Restorative Therapies Group and adopted enterprise-wide — recognized with a Global Operations award.
Also available: manufacturing strategy & global operations, fractional CTO/COO services for venture-stage MedTech, and board advisory & executive coaching.
Uniquely among MedTech consultants, Jen designed, deployed, and scaled two proprietary continuous-improvement programs inside Medtronic — both nationally recognized, both available as packaged engagements.
An employee-driven innovation and Lean engagement program: "Idea Entrepreneurs" pitch improvement ideas to "Idea Investors," and winning teams — staffed with a Project Manager, Black Belt mentor, and new Green Belts — implement them through DMAIC. A high-engagement CI culture with real, measurable outcomes.
A custom onsite certification program that develops your employees into certified change agents for quality — building internal CI capability instead of indefinite dependence on outside consultants.
| Company | Product | Category |
|---|---|---|
| Medtronic / Osteotech | MagniFuse™ | Bone Grafting |
| Medtronic / Osteotech | Plexur M® | Bone Grafting |
| Medtronic / Osteotech | Kinesis™ BMAC | Stem Cell / Bone Marrow Aspirate |
| Integra LifeSciences | DuraGen™ XS | Dural Regeneration Matrix |
| Integra LifeSciences | Suturable DuraGen™ | Dural Regeneration |
| Integra LifeSciences | NeuraGen® 3cm | Nerve Regeneration |
| Integra LifeSciences | NeuraWrap™ 4cm | Nerve Regeneration |
| Integra LifeSciences | 1.5mm NeuraGen® | Nerve Regeneration |
| Integra LifeSciences | MasterGraft Matrix Strips | Bone Graft |
Operational excellence leadership across 13 manufacturing sites spanning the U.S., Europe, and Latin America:
Currently accepting a limited number of consulting engagements for medical technology, biologics, and life sciences companies. If you're looking for a senior advisor with real-world executive experience — not just frameworks — I'd welcome a conversation.